CANBRIDGE PHARMACEUTICALS INC revenue for the last year amounted to 113.17 M HKD, the most of which — 91.83 M HKD — came from its highest performing source at the moment, Development, Production, Marketing and Sale of Medical Products, the year earlier bringing 37.56 M HKD. The greatest contribution to the revenue figure was made by Other Regions — last year it brought CANBRIDGE PHARMACEUTICALS INC 55.21 M HKD, and the year before that — 28.69 M HKD.